A Conversation on Drug Development for Rare Diseases
Written by Mary Dunkle on July 7, 2022
Explore the five steps in drug development and discover new opportunities to get involved
More than 95% of rare disease patients lack an FDA-approved treatment for their condition. However, today there are more opportunities than ever before for patients, caregivers and patient organizations to play a key role in advancing R&D… Read More